Abstract:Background Maternal-infant transmission of hepatitis B virus(HBV) occurs even after passive-active immunization. Some scholars speculate that in-utero infection may be the main cause of immunoprophylaxis failure. However, there is a lack of evidence about the possible occurrence periods of perinatal transmission. Methods From 2008 to 2012, 428 pairs of HBsAg-positive mothers and neonates were enrolled and 385 infants aged 8–12 months were followed. HBV markers (HBsAg, anti-HBs, HBeAg, anti-HBe, anti-HBc, HBV-DNA) were performed on all subjects. Results Of mothers who were positive for HBsAg, HBeAg, HBV-DNA, 35.1 %, 94.3 %, 12.7 % of their neonates were positive for those indices, respectively. Neonates’ mean titers of those indices were significantly lower than their mothers’. There were no significant differences in rates of positivity and mean titers of anti-HBe and anti-HBc between neonates and mothers. Most of the positive indices turned negative during the follow-up period. Immunoprophylaxis failed in seventeen infants: four infants had HBV-DNA > 6 log 10 copies/mL both at birth and in follow-up; in six infants, mean viral load was 3.72 ± 0.17 log 10 copies/mLat birth and 7.62 ± 0.14 log 10 copies/mL at follow-up; seven infants were HBV-DNA negative at birth but were found to have > 6 log 10 copies/mL during follow-up. Infants that were immunoprophylaxis failures were all born to HBeAg-positive mothers with HBV-DNA > 6 log 10 copies/mL. Conclusions The placental barrier can partly prevent maternal HBsAg, HBeAg, HBV-DNA from passing through to fetus. Performing HBsAg, HBeAg, HBV-DNA once at birth can neither diagnose nor exclude maternal-infant transmission. The diagnosis of infection period depends on the dynamic changes in viral load from birth through the follow-up period but whether the infection occurred in utero, at delivery or during the neonatal period could not be determined.

Correlation Between Vertical Transmission of Hepatitis B Virus and the Expression of HBsAg in Ovarian Follicles and Placenta

The presence and expression of the hepatitis B virus in human oocytes and embryos

Hepatitis B Virus in Oocytes and Embryos: Pregnancy Outcomes and Children’s Health

Relationship Between HBV Cccdna Expression in the Human Ovary and Vertical Transmission of HBV.

[Relationship Between the Expression of HBV DNA, HBV Cccdna in Human Ovary Tissues and the HBV Intrauterine Infection].

Study of the relationship in pregnant women between hepatitis B markers and a placenta positive for hepatitis B surface antigen

[A Molecular Epidemiologic Study on the Mechanism of Intrauterine Transmission of Hepatitis B Virus].

Hepatitis B Virus Expression and Replication in Ovum and the Influencing Factors.

Relation between HBV mRNA in the embryo of HBV patients and vertical transmission

[An Investigation on the Transmission Routes and Early Diagnosis of Intrauterine Infection Induced by Hepatitis B Virus].

Analysis of the Factors Correlated to HBV Cccdna in Human Ovarian in Pregnant Women with Hepatitis B E Antigen Positive

Study on HBsAg and HBeAg in neonate's gastric juice and its correlation to hepatitis B virus intrauterus infection

Presence of HBsAg, HBcAg, and HBVDNA in ovary and ovum of the patients with chronic hepatitis B virus infection.

The role of placental Toll-like receptors in HBV vertical transmission

Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates

Involvement of Viperin in Prevention of Intrauterine Transmission of Hepatitis B Virus

[The Role of Placenta in Hepatitis B Virus Intrauterine Transmission].

Relationship between HBeAg and intra-uterine vertical transmission of hepatitis B virus

Role of maternal viremia and placental infection in hepatitis B virus intrauterine transmission.

The Presence of HBV Mrna in the Fertilized in Vitro Embryo of HBV Patients Confirms Vertical Transmission of HBV Via the Ovum

Risk factors and prophylactic strategies of hepatitis B virus vertical transmission